Nuveen LLC acquired a new position in Cognex Corporation (NASDAQ:CGNX - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 404,420 shares of the scientific and technical instruments company's stock, valued at approximately $12,064,000. Nuveen LLC owned about 0.24% of Cognex as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC lifted its holdings in shares of Cognex by 439.4% in the 1st quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock worth $29,000 after acquiring an additional 791 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Cognex by 155.3% during the 1st quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock worth $32,000 after buying an additional 646 shares in the last quarter. UMB Bank n.a. lifted its holdings in Cognex by 105.5% during the 1st quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock worth $38,000 after buying an additional 657 shares in the last quarter. Global X Japan Co. Ltd. acquired a new stake in Cognex during the 1st quarter worth approximately $38,000. Finally, Quarry LP acquired a new stake in Cognex during the 4th quarter worth approximately $53,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.
Cognex Trading Up 0.8%
Shares of NASDAQ CGNX traded up $0.36 during mid-day trading on Wednesday, reaching $44.25. The company had a trading volume of 2,223,824 shares, compared to its average volume of 2,429,914. Cognex Corporation has a 52-week low of $22.67 and a 52-week high of $45.03. The stock has a market cap of $7.43 billion, a P/E ratio of 62.32 and a beta of 1.47. The firm has a 50 day simple moving average of $36.68 and a two-hundred day simple moving average of $32.25.
Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company had revenue of $249.09 million for the quarter, compared to the consensus estimate of $246.70 million. During the same period last year, the firm posted $0.23 EPS. Cognex's revenue for the quarter was up 4.2% on a year-over-year basis. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts expect that Cognex Corporation will post 0.61 EPS for the current year.
Cognex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th will be given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Thursday, August 14th. Cognex's dividend payout ratio (DPR) is presently 45.07%.
Analysts Set New Price Targets
A number of research firms have issued reports on CGNX. Needham & Company LLC increased their target price on shares of Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. UBS Group increased their target price on shares of Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Robert W. Baird increased their target price on shares of Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a report on Monday, June 16th. Citigroup reissued a "neutral" rating and issued a $37.00 price objective (up from $30.00) on shares of Cognex in a research report on Monday, July 14th. Finally, DA Davidson increased their price objective on shares of Cognex from $32.00 to $35.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $42.31.
Get Our Latest Stock Analysis on CGNX
Cognex Company Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Articles

Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.